Diabetic Foot Disease
14
1
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (14)
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers
Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot
Periosteal Distraction With Skin Grafting for DFU
Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters
FDG-PET Imaging in Complicated Diabetic Foot
NAFF Arabic Validation Study
Development and Application of a Decision-Making Aid Tool for Amputation Surgery in Diabetic Foot Patients Based on the Ottawa Decision Support Framework
Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers
Implementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)
Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
Predictive Analysis of Diabetic Foot Ulcer
Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients
Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients
Diabetic Foot Education